Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Studies on the antihypertensive action of the optical isomers of propranolol in man.

× No keyword cloud information.

7 in total

1. Antihypertensive action of propranolol. Specific antirenin responses in high and normal renin forms of essential, renal, renovascular and malignant hypertension.

Authors: F R Bühler; J H Laragh; E D Vaughan; H R Brunner; H Gavras; L Baer
Journal: Am J Cardiol Date: 1973-09-20 Impact factor: 2.778

2. Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases.

Authors: F R Bühler; J H Laragh; L Baer; E D Vaughan; H R Brunner
Journal: N Engl J Med Date: 1972-12-14 Impact factor: 91.245

3. Plasma propranolol levels in adults with observations in four children.

Authors: D G Shand; E M Nuckolls; J A Oates
Journal: Clin Pharmacol Ther Date: 1970 Jan-Feb Impact factor: 6.875

4. Optical isomers of propranolol.

Authors: R Howe; R G Shanks
Journal: Nature Date: 1966-06-25 Impact factor: 49.962

5. USE OF PROPRANOLOL (INDERAL) IN TREATMENT OF HYPERTENSION.

Authors: B N PRICHARD; P M GILLAM
Journal: Br Med J Date: 1964-09-19

6. Treatment of hypertension with propranolol.

Authors: B N Prichard; P M Gillam
Journal: Br Med J Date: 1969-01-04

7. The biological properties of the optical isomers of propranolol and their effects on cardiac arrhythmias.

Authors: A M Barrett; V A Cullum
Journal: Br J Pharmacol Date: 1968-09 Impact factor: 8.739

7 in total

13 in total

1. Haemodynamic effects of beta-adrenorecptor blockers in hypertension.

Authors: B Ablad; B Ljung; R Sannerstedt
Journal: Drugs Date: 1976 Impact factor: 9.546

Review 2. Hypertension: which beta-blocker?

Authors: H J Waal-Manning
Journal: Drugs Date: 1976-12 Impact factor: 9.546

Review 3. The applied pharmacology of beta-adrenoceptor antagonists (beta blockers) in relation to clinical outcomes.

Authors: J D Fitzgerald
Journal: Cardiovasc Drugs Ther Date: 1991-06 Impact factor: 3.727

4. Dissociation between duration of plasma catecholamine and blood pressure responses to beta-adrenergic blockade in normotensive subjects during physical exercise.

Authors: G Planz; R Planz
Journal: Eur J Clin Pharmacol Date: 1981-01 Impact factor: 2.953

5. Stereoselective hemodynamic effects of (R)-and (S)-propranolol in man.

Authors: K Stoschitzky; W Lindner; M Rath; C Leitner; G Uray; G Zernig; T Moshammer; W Klein
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 1989-04 Impact factor: 3.000

6. Pharmacokinetics and dynamics of penbutolol in humans: evidence for pathway-specific stereoselective clearance.

Authors: H R Ochs; P Hajdú; D J Greenblatt
Journal: Klin Wochenschr Date: 1986-07-15

7. Duration and selectivity in beta-adrenoceptor blocking action of a beta-adrenoceptor blocking drug, D-32 in conscious dogs.

Authors: N Himori; S Honma; A Izumi; T Ishimori
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 1981-02 Impact factor: 3.000

8. A comparison of the antihypertensive effect of atenolol (ICI 66 082) and propranolol.

Authors: L Hansson; A Westerlund; H Aberg; B E Karlberg
Journal: Eur J Clin Pharmacol Date: 1976-03-22 Impact factor: 2.953

9. Selective effect of adjuvant arthritis on the disposition of propranolol enantiomers in rats detected using a stereospecific HPLC assay.

Authors: M Piquette-Miller; F Jamali
Journal: Pharm Res Date: 1993-02 Impact factor: 4.200

10. Comparative studies of (--)-, (+/-)-propranolol, atenolol, guanethidine, bretylium and tetracaine on adrenergic transmission.

Authors: M Kaiho; T Kubo; Y Misu
Journal: Br J Pharmacol Date: 1981-10 Impact factor: 8.739